About Daniel Davis
Daniel Davis is a chief strategy officer and director at Instylla.
Form D filings also name Daniel Davis as an executive officer and director at Imperative Care.
Daniel Davis first appears on SEC filings in 2021.
Experience
This experience comes from Daniel Davis's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Davis in the role, so the role may have started earlier or lasted longer.
VE
Vesalio Current
Board Member and Advisor to the CEO
2026 – Present
Instylla, Inc. Current
Chief Strategy Officer and director
Board Member, Compensation Committee and Audit Committee Member (2025 – Present)
2025 – Present · Bedford, MA
Instylla makes injectable materials that doctors use to block blood flow to tumors.
Imperative Care, Inc.
Advisor to the CEO (2020 – 2026)
Director
2020 – 2026 · Campbell, CA
Makes devices that help clinicians remove blood clots from stroke and vascular patients.
KN
Kandu Health™ (merged with NeuroLutions)
Board Member
2021 – 2024
TC
Truvic (acquired by Imperative Care)
Board Member
2020 – 2023
PI
Penumbra, Inc.
President and Chief Commercial Officer
2007 – 2019
BS
Boston Scientific
Neurovascular Stent Proctor
2006 – 2007
ST
Stryker
Principal Product Manager - Neurovascular Embolization
2004 – 2006
NC
Newell Company
Senior Product Manager
2001 – 2004
TR
Trilogy
Business Development
2000 – 2001
Key Colleagues at Startups
The people Daniel Davis works with at each company, as listed on that company's latest Form D.
Instylla, Inc. · Form D/A, Jul 28, 2026
SC
Sean Cheng
Managing Director
FK
Farhad Khosravi
Director
TD
Tasneem Dohadwala
Director
SC
Steven Cagnetta
Executive officer
DZ
Darshana Zaveri
Director
Sean Boyle
CEO and director
AS
Amarpreet Sawhney
FOUNDER and CHAIRMAN
HC
Henry Chen
FOUNDING and MANAGING PARTNER, director
Imperative Care, Inc. · Form D, Jul 22, 2021
AS
Amar Sawhney
Director
NH
Nick Hopkins
Director
MG
TB
Tara Butler
Director
JR
James Rogers
Director
JH
John Hamre
Director
FY
Fan Yu
Director
AH
Andrew Hack
Director
HC
Henry Chen
Director
FK
Farhad Khosravi
Executive officer and director